Harmony Biosciences Holdings Inc Revenue per Employee (HRMY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Harmony Biosciences Holdings inc   (NASDAQ: HRMY)
 

Harmony Biosciences Holdings Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 12.61% in the third quarter 2026, year on year to cumulative value of $990 million, Harmony Biosciences Holdings Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,379,874. The productivity of Harmony Biosciences Holdings Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 20 other companies have achieved higher revenue per employee. While Harmony Biosciences Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 207 to 292. Harmony Biosciences Holdings Inc has 293 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HRMY Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 12.61 % 30.42 % 16.95 % 21.49 % 28.9 %
Sales per Employee (TTM) $ 3,379,874 3,277,102 3,069,102 2,962,836 2,814,805
HRMY's Total Ranking # 292 # 207 # 222 # 183 #
Seq. Revenue Change 2.92 % 21.6 % -12.38 % 2.69 % 19.2 %

HRMY Company Profile >> Back to HRMY Efficiency Comparisons >> Compare HRMY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 21
Overall Market # 292

Revenue per Employee Statistics
High Average Low
$ 3,069,102 $ 1,796,583 $ 155,662
(Mar 31 2026)   (Sep 30 2020)



Financial Statements
Harmony Biosciences Holdings Inc 's Revenue MRQ $ 269 Millions Visit HRMY's Income Statement
Harmony Biosciences Holdings Inc 's Revenues TTM $ 990 Millions Visit HRMY's aggregate revenue growth
What are HRMY's Sales? Visit HRMY's Sales by Segment




Other Ratios
Harmony Biosciences Holdings Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
HRMY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for HRMY's Competitors
Revenue per Employee for HRMY's Suppliers
Revenue per Employee for HRMY's Customers

You may also want to know
HRMY's Sales Growth Rates HRMY's Pe Price to earnings ratio HRMY's Receivables Turnover Ratio HRMY's Stock Quote
HRMY's Net Income Growth Rates HRMY's Ps Price to Sales ratio HRMY's Sales per Employee HRMY's Asset Turnover Ratio
HRMY's Net Margin HRMY's Pb Price to Book ratio HRMY's Financial Strength Ratios HRMY's Dividend Payout Ratio
Date modified: 2026-11-05T10:38:16+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Ligand Pharmaceuticals Incorporated  5,400,574.47 $ 253.827  Million 47 
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.